Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is April 10, 2024.
All times in Eastern Daylight Time.
-
LONDON--(BUSINESS WIRE)-- COMMONWEALTH BANK OF AUSTRALIA Issue of GBP 1,000,000,000.00 Floating Rate covered bonds due Hanuary 2025 Series 84 Tranche 1 MTN ISSUE NAME. Our Ref. MM4692 ISIN Code. X... more »
-
LONDON--(BUSINESS WIRE)-- Australia and New Zealand Banking Group Issue of AUD 20,000,000 floating rate notes due 9 April 2025 series 1955 Tranche 1 MTN ISSUE NAME. Our Ref. ML2406 ISIN Code. XS18... more »
-
LONDON--(BUSINESS WIRE)-- Commonwealth Bank of Australia Issue of GBP 200,000,000.00 Floating Rate Notes due 16 October 2024 Series 6551 Tranche 1 MTN ISSUE NAME. Our Ref. MQ1709 ISIN Code. XS2704... more »
-
McKay Brothers Launches Fastest London-Stockholm Private BandwidthGENEVA--(BUSINESS WIRE)--McKay Brothers International (MBI) launched the lowest latency private bandwidth between London and Stockholm. McKay’s ultra-low latency service connects key European excha... more »
-
LONDON--(BUSINESS WIRE)-- Commonwealth Bank of Australia Issue of USD 100,000,000.00 Floating Rate Notes due 13 July 2024 Series no. 6532 Tranche 1 MTN ISSUE NAME. Our Ref. MP8310 ISIN Code. XS264... more »
-
LONDON--(BUSINESS WIRE)-- Commonwealth Bank of Australia Issue of USD 100,000,000.00 Floating Rate Notes due 14 July 2024 Series 6531 Tranche 1 MTN ISSUE NAME. Our Ref. MP8186 ISIN Code. XS2649640... more »
-
Sensorion annonce sa participation à la conférence Van Lanschot Kempen’s Life SciencesMONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), société de biotechnologie pionnière au stade clinique, spécialisée dans le développement de nouvelles thérap... more »
-
Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences ConferenceMONTPELLIER, France--(BUSINESS WIRE)--Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences Conference more »
-
TheraVet Reports 2023 Full Year and 2024 First Quarter RevenuesGOSSELIES, Belgium--(BUSINESS WIRE)--Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, reports its 2023 full... more »
-
TheraVet publie son chiffre d’affaires pour l’exercice 2023 et pour le premier trimestre 2024GOSSELIES, Belgique--(BUSINESS WIRE)--Regulatory News: TheraVet (ISIN : BE0974387194 – ticker : ALVET), société de biotechnologie pionnière dans le traitement des maladies ostéoarticulaires des ani... more »
-
Lattice lance une solution avancée de contrôle de mouvementHILLSBORO, Oregon--(BUSINESS WIRE)--Lattice Semiconductor (NASDAQ : LSCC), le leader des programmables écoefficients, annonce aujourd’hui une nouvelle plateforme de référence de contrôle de mouveme... more »
-
Lattice liefert fortschrittliche BewegungssteuerungslösungHILLSBORO, Oregon--(BUSINESS WIRE)--Lattice Semiconductor (NASDAQ: LSCC), der führende Anbieter von programmierbaren Low-Power-Systemen, kündigte heute eine neue Motion-Control-Referenzplattform an... more »
-
Innate Pharma présente des données d’efficacité précliniques pour IPH45, son conjugué anticorps-médicament innovant ciblant nectine-4 a l’AACR 2024MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que les premières données préclinique... more »
-
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug ConjugateMARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that first preclinical data for its asset IPH45... more »
-
ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News: Azelis (Brussels:AZE), a leading global innovation service provider in the specialty chemicals and food ingredients industry, announces that it h... more »